NCT07439315
The Effect of a Novel Joint Distraction Knee Orthosis for Treating Medial Knee Osteoarthritis
StatusNot Yet Recruiting
PhaseNot applicable
SponsorIcarus Medical Innovations
Primary completion (estimated)
At risk: Primary completion moved 1 year 3 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary completion pushed from Jun 1, 2026 to Sep 1, 2027 Show 4 more changesShow less
- Start date: Mar 1, 2026 to Jan 1, 2027
- Eligibility criteria expanded, about 23 words
- Study completion pushed from Aug 1, 2026 to Dec 1, 2027
- Publications: details revised at 25 of 28 entries
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Knee Injury and Osteoarthritis Outcome Score (KOOS)
Timeframe: Baseline, 2, 4, 8, 12 weeks
European Quality of Life-5 Dimensions (EQ-5D-5L)
Timeframe: Baseline, 2, 4, 8, 12 weeks.
Visual Analogue Scale (VAS)
Timeframe: Baseline, 2, 4, 8, 12 weeks.
Functional Mobility Assessments
Timeframe: Baseline, 2, 4, 8, 12 weeks
Functional Mobility Assessment
Timeframe: Baseline, 2, 4, 8, 12 weeks
Arms and interventions
The Effect of a Novel Joint Distraction Knee Orthosis for Treating Medial Knee OsteoarthritisExperimental
Patients experiencing unicompartment (medial or lateral) osteoarthritis will receive Icarus Adonis Joint Distraction brace. Patients will wear the brace for 12 weeks and document how often they wear the brace and their pain scores. Patients will fill out outcome surveys at 2, 4, 6, 8, and 12 weeks.
Devices: Medial joint distraction brace
Sites
1 site in 1 country
- Icarus Medical InnovationsCharlottesville, Virginia, United States